RadNet Q4 2025 Revenue and EBITDA Hit Record Highs as Digital Health Segment Surges 48%
02 Mar 2026 · 12:31 UTC · CoinCentral RSS Feed · Original source
Read original at CoinCentral RSS Feed →
Summary
RadNet, Inc. (RDNT), a medical imaging center operator, reported record Q4 2025 results with revenue up 14.8% year-over-year, driven by imaging center expansion and operational efficiency improvements. The company's Digital Health segment grew 48%, supported by AI-powered diagnostic solutions and subscription revenue stability. MRI, CT, and PET/CT imaging volumes rose double digits, with strong same-center growth. For 2026, RadNet guided for imaging revenue growth of 17–19%, EBITDA growth of 18–22%, and free cash flow growth of 29–41%. The company also completed the acquisition of Gleamer to expand its AI offerings, with multiple FDA clearances anticipated throughout 2026.
Why it matters
RadNet is a medical imaging company with no discernible connection to blockchain, DeFi, digital assets, or cryptocurrency infrastructure. Its Q4 2025 earnings beat and 2026 guidance are relevant to equity investors in the healthcare/medtech sector, not crypto markets. The sole source is CoinCentral, a crypto publication, which lends this article a low contextual credibility score for its placement. There are no macro-economic signals embedded in this story (e.g., rate changes, inflation data) that would indirectly affect crypto. The AI angle in RadNet's Digital Health segment (Gleamer acquisition, FDA clearances) is healthcare-specific AI, not blockchain AI infrastructure. Consequently, all market impact probabilities across both BTC and altcoin assets and all timeframes are assessed as negligible (~0.02), reflecting only baseline market noise rather than any causal mechanism from this article.
Expected impact
This article covers RadNet, Inc. (RDNT), a U.S. medical imaging and digital health company, reporting strong Q4 2025 financial results. The content is unrelated to cryptocurrency markets. No measurable impact on BTC or altcoin prices is expected across any timeframe. The article's presence on a crypto-focused outlet (CoinCentral) appears incidental or editorially misplaced, as RadNet operates entirely within the traditional healthcare sector.